Profusa, Inc. (PFSA)
Data as of , from SEC Form 4 filings.
See up to 3 months of PFSA. The 7-day demo opens the 1M and 3M ranges and puts PFSA on your watchlist.
Start 7-day demoLatest PFSA insider trades
About Profusa, Inc. (PFSA)
Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.
- NEW YORK, NY
- 2025
- XNAS
PFSA Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 8 | 37,635 | $37K |
| Open-market sale | 6 | 67,556 | $153K |
| Other acquisition / disposition | 8 | 1,294,305 |
PFSA insider transactions (Form 4)
4123 Form 4 filings on record, the earliest from Jan 26, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Fred S. Knechtel - Officer | Other | Common Stock | 54,323 footnote F1 | $0.00 | - | |
| Fred S. Knechtel - Officer | Other | Common Stock | 301,991 | $0.00 | - | |
| ||||||
| Jack E. Stover - Officer | Other | Common Stock | 32,018 footnote F1 | $0.00 | - | |
| Jack E. Stover - Officer | Other | Common Stock | 301,991 | $0.00 | - | |
| ||||||
| Fred S. Knechtel - Officer | Other | Common Stock | 301,991 footnote F1 | $4.28 footnote F2 | $1.29M | |
| Fred S. Knechtel - Officer | Other | Convertible Promissory Note | 0 | $0.00 | - footnote F4 | |
| ||||||
| Jack E. Stover - Officer | Other | Common Stock | 301,991 footnote F1 | $4.28 footnote F2 | $1.29M | |
| Jack E. Stover - Officer | Other | Convertible Promissory Note | 0 | $0.00 | - footnote F4 | |
| ||||||
| HRT FINANCIAL LP - 10% Owner | Open-market sale | Common Stock | 18,395 | $5.94 | $109K | |
| HRT FINANCIAL LP - 10% Owner | Open-market sale | Common Stock | 3,163 | $3.61 | $3K | |
| HRT FINANCIAL LP - 10% Owner | Open-market purchase | Common Stock | 5,585 | $3.86 | $5K | |
| HRT FINANCIAL LP - 10% Owner | Open-market sale | Common Stock | 42,411 | $3.55 | $38K | |
| HRT FINANCIAL LP - 10% Owner | Open-market purchase | Common Stock | 4,016 | $3.78 | $4K | |
| HRT FINANCIAL LP - 10% Owner | Open-market sale | Common Stock | 2,280 | $3.88 | $2K | |
| HRT FINANCIAL LP - 10% Owner | Open-market sale | Common Stock | 383 | $3.77 | $361 | |
| HRT FINANCIAL LP - 10% Owner | Open-market purchase | Common Stock | 926 | $3.77 | $873 | |
| HRT FINANCIAL LP - 10% Owner | Open-market sale | Common Stock | 924 | $3.78 | $874 | |
| HRT FINANCIAL LP - 10% Owner | Open-market purchase | Common Stock | 14,556 | $3.83 | $14K | |
| HRT FINANCIAL LP - 10% Owner | Open-market purchase | Common Stock | 1,368 | $3.82 | $1K | |
| HRT FINANCIAL LP - 10% Owner | Open-market purchase | Common Stock | 1,063 | $4.04 | $1K | |
| HRT FINANCIAL LP - 10% Owner | Open-market purchase | Common Stock | 8,811 | $4.20 | $9K | |
| HRT FINANCIAL LP - 10% Owner | Open-market purchase | Common Stock | 1,310 | $4.04 | $1K | |
| Jack E. Stover - Director | Open-market purchase | Convertible Promissory Note | 0 | $186,979,600.00 | - | |
| Fred S. Knechtel - Officer | Open-market purchase | Convertible Promissory Note | 0 | $186,979,600.00 | - | |
| Peter O'Rourke - Director | Other | Common Stock | 107,750 | - footnote F1 | - | |
| Peter O'Rourke - Director | Other | Warrants | 15,250 | $0.00 | - | |
| ||||||
| Jack E. Stover - Director | Other | Common Stock | 553,665 | - footnote F1 | - | |
| Jack E. Stover - Director | Other | Warrants | 380,280 | $0.00 | - | |
| ||||||
| Lauren Chung - Director | Other | Common Stock | 30,000 | - footnote F1 | - | |
| ||||||
| Jack E. Stover - Director | Grant or award | Stock Options | 221,794 footnote F1 | $0.00 | - | |
| Jack E. Stover - Director | Grant or award | Stock Options | 52,866 footnote F2 | $0.00 | - | |
| ||||||
| Rajesh Asarpota - Director | Grant or award | Stock Options | 221,794 footnote F1 | $0.00 | - | |
| Rajesh Asarpota - Director | Grant or award | Stock Options | 52,866 footnote F2 | $0.00 | - | |
| ||||||
| Lauren Chung - Director | Grant or award | Stock Options | 221,794 footnote F1 | $0.00 | - | |
| Lauren Chung - Director | Grant or award | Stock Options | 52,866 footnote F2 | $0.00 | - | |
| ||||||
| Peter O'Rourke - Director | Grant or award | Stock Options | 221,794 footnote F1 | $0.00 | - | |
| Peter O'Rourke - Director | Grant or award | Stock Options | 52,866 footnote F2 | $0.00 | - | |
| ||||||
| NorthView Sponsor I, LLC - 10% Owner | Other | Common Stock | 4,743,750 | - footnote F1 | - | |
| NorthView Sponsor I, LLC - 10% Owner | Other | Warrants | 5,162,500 | $0.00 | - | |
| ||||||
| Fred S. Knechtel - Officer | Other | Common Stock | 818,961 | - footnote F1 | - | |
| Fred S. Knechtel - Officer | Other | Warrants | 516,863 | $0.00 | - | |
| ||||||
PFSA insider trading FAQ
What is the latest insider trade for PFSA?
Profusa, Inc. (PFSA) had 12 insider filings in the last 90 days, with the most recent on 2026-09-04. The full record for PFSA runs to 23 Form 4 filings, the earliest from 2026-01-26. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying PFSA stock?
8 insider purchases of PFSA were filed in the last 90 days, totaling $37K.
How many insiders are selling PFSA stock?
6 insider sales of PFSA were filed in the last 90 days, totaling $153K.
Where can I see PFSA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects PFSA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Fred S. Knechtel view on EDGAR
- - Jack E. Stover view on EDGAR
- - Fred S. Knechtel view on EDGAR
- - Jack E. Stover view on EDGAR
- - HRT FINANCIAL LP view on EDGAR
- - HRT FINANCIAL LP view on EDGAR
- - HRT FINANCIAL LP view on EDGAR
- - HRT FINANCIAL LP view on EDGAR
- - HRT FINANCIAL LP view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Insider activity in Health Care
- Where PFSA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow PFSA with a 7-day demo
- PFSA on your watchlist
- Every PFSA Form 4 filing on record
- Up to 3 months of PFSA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive